Clinical Trials on Circulating Tumor Cell in Sweden

Total 756 results

Karolinska University Hospital
Philips Healthcare

Completed

Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument

Glioblastoma | Surgical Margin

Sweden
Uppsala University Hospital

Recruiting

A MolEcularly Guided Anti-Cancer Drug Off-Label Trial (MEGALiT)

Solid Tumor

Sweden
Lokon Pharma AB
Precision Oncology LLC

Completed

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

Malignant Melanoma

Sweden, United States
University Hospital Heidelberg
German Cancer Research Center

Recruiting

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (INFORM2 NivEnt)

Solid Tumor | CNS Tumor

France, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
Region Skane
Bibb Instruments AB; Key2Compliance

Completed

Investigation to Evaluate Safety and Efficacy of the Endodrill Model X Biopsy Instrument

Tumor Sampling

Sweden
Gustav Stalhammar
The Swedish Society of Medicine; Swedish Cancer Society; Karolinska Trial Alliance and other collaborators

Recruiting

Adjuvant Melatonin for Uveal Melanoma (AMUM)

Uveal Melanoma | Uveal Melanoma, Posterior, Medium/Large Size | Eye Cancer, Intraocular Melanoma

Sweden
Vastra Gotaland Region
Bristol-Myers Squibb

Active, not recruiting

Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases (SCANDIUM II)

Liver Metastases | Uveal Melanoma

Sweden
Alligator Bioscience AB

Completed

Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017

Neoplasms | Solid Tumor

Sweden
Vastra Gotaland Region
Merck Sharp & Dohme LLC; Syndax Pharmaceuticals

Completed

Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye (PEMDAC)

Metastatic Uveal Melanoma

Sweden
Karolinska University Hospital
Schering Nordiska AB

Completed

Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia

B-CLL

Sweden
Cecilia Soderberg-Naucler
Karolinska University Hospital; Karolinska Institutet

Recruiting

A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients (VIGAS2)

Glioblastoma Multiforme

Sweden
Novartis Pharmaceuticals

Terminated

Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET (COOPERATE-2)

Islet Cell Tumor

France, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
Vastra Gotaland Region

Completed

Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion. (ILP-NfL)

Malignant Melanoma

Sweden
Vastra Gotaland Region
Advanced Accelerator Applications

Active, not recruiting

177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours (LuPARP)

Thymoma | Neuroendocrine Tumors | Mesothelioma | Clinical Trial, Phase I

Sweden
Karolinska Institutet

Unknown

A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis

Stem Cell Transplantation | Hemorrhagic Cystitis | Decidual Stromal Cells

Sweden
Jakob Stenman
Novartis; Advanced Accelerator Applications

Recruiting

177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma (LuDO-N)

Neuroblastoma | Neuroblastoma Recurrent

Sweden, Denmark, Lithuania, Norway, Netherlands
Ipsen

Completed

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours (STREET)

Gastroenteropancreatic Neuroendocrine Tumours

Sweden
Novartis Pharmaceuticals

Completed

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe (RAMSETE/CDE16)

Carcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non Functioning

Sweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
CytoVac A/S

Completed

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma (ALECSAT)

Glioblastoma

Sweden
SentoClone AB

Unknown

SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Malignant Melanoma

Sweden
AstraZeneca

Completed

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

Glioblastoma

Sweden
Region Örebro County

Completed

Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia

Vaccine Response | CLL

Sweden
Region Örebro County

Recruiting

Dermatoscopy Guided Resection for Skin Cancer

Basal Cell Carcinoma | Surgical Margin | Cutaneous Squamous Cell Carcinoma

Sweden
Lund University

Withdrawn

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Vestibular Schwannoma

Sweden
Clavis Pharma

Completed

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Malignant Melanoma

United States, Sweden, Norway
Clavis Pharma

Completed

Clinical Study of Previously Untreated Patients With Malignant Melanoma

Neoplasm Metastasis | Malignant Melanoma

United States, Norway, Sweden
Karolinska Institutet

Completed

Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study

Vestibular Schwannoma

Sweden
Lund University

Withdrawn

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Vestibular Schwannoma

Sweden
Axelar AB

Completed

A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer

Solid Tumors

Sweden
Rigshospitalet, Denmark
Danish Center for Interventional Research in Radiation Oncology (CIRRO)

Terminated

Image Guided Reirradiation of High-grade Glioma

Glioblastoma | Malignant Glioma

Sweden, Denmark
Lidds AB

Terminated

Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

Solid Tumor

Lithuania, Sweden, Denmark
The Netherlands Cancer Institute
Bristol-Myers Squibb

Active, not recruiting

Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN-neo)

Malignant Melanoma Stage III

Austria, Netherlands, Australia, Sweden
Incyte Corporation

Active, not recruiting

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Cervical Cancer | Nasopharyngeal Carcinoma | Advanced Solid Tumors | Mesothelioma | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Anal Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1) | Urothelial... and other conditions

Finland, United States, United Kingdom, Belgium, Sweden, Denmark, Norway
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

Symptomatic Refractory Resistant Carcinoid Disease

United Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
Alligator Bioscience AB

Completed

Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015

Neoplasms | Solid Tumor

Denmark, Sweden
Region Skane

Terminated

Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome (AUSC)

Adrenal Tumour With Mild Hypercortisolism

Norway, Sweden, Denmark
Uppsala University
Karolinska University Hospital; Uppsala University Hospital; AFA Insurance; Swedish...

Completed

CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.

B Cell Lymphoma | B Cell Leukemia

Sweden
Peter Siesjö
Lund University; Region Skane; Skane University Hospital; Lantmannen Medical AB

Completed

Antisecretory Factor in Primary Glioblastoma 1 (AFGBM1)

Glioblastoma | Chemotherapy Effect | Cerebral Edema

Sweden
Uppsala University
Uppsala University Hospital; AFA Insurance

Completed

CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy

B-Cell Lymphoma | B-cell Leukemia

Sweden
Vastra Gotaland Region

Recruiting

Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion (NivoILP)

Melanoma | In-Transit Metastasis

Sweden, Netherlands
Merck Sharp & Dohme LLC

Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Melanoma | Lymphoma | Solid Tumor | Classical Hodgkin Lymphoma | Microsatellite-instability-high Solid Tumor

France, Germany, Italy, Netherlands, Sweden, United Kingdom, Brazil, Israel, Korea, Republic of, United States
Ipsen

Completed

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs (EXPLAIN)

Gastroenteropancreatic Neuroendocrine Tumors

Finland, Norway, Sweden, Denmark, Latvia, Lithuania, Estonia
Uppsala University
Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaborators

Recruiting

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults (PRO-CNS)

Arteriovenous Malformation | Central Nervous System Tumour

Sweden
Region Skane

Recruiting

Monitoring and Early Response Evaluation Using HPV DNA - A Study on Patients With HPV-positive Throat Cancer (MER-HPV) (MER-HPV)

Oropharynx Squamous Cell Carcinoma

Sweden
Karolinska University Hospital

Completed

Photochemotherapy and Graft-versus-leukemia in Acute-leukemia

AML | ALL | Acute GVHD | Tumor Immunity

Sweden
Lund University Hospital
Valcuria

Completed

Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma (VALFRID)

Diffuse Large B-cell Lymphoma

Sweden
Novartis Pharmaceuticals

Completed

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Pancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell Carcinoma

United States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
Francisco Baldaque-Silva

Recruiting

Role of Doppler Endoscopic Probe in the Diagnosis of Subepithelial Gastrointestinal Lesions. (DopplerSEL)

Subepithelial Tumors of the Upper Gastrointestinal Tract

Sweden
XVIVO Perfusion

Terminated

Acute Kidney Injury After Cardiac Surgery

Acute Kidney Injury | Extracorporeal Circulation; Complications | Cardiac Surgical Procedures

Sweden
Novartis Pharmaceuticals

Completed

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

Neuroendocrine Tumors

Germany

Clinical Trials on Circulating Tumor Cell in Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations